ICEC0942, an orally bioavailable selective inhibitor of CDK7 for breast cancer
File(s)10.1007_s10549-016-3898-5.pdf (320.46 KB)
Published version
Author(s)
Type
Conference Paper
Date Issued
2016-08-20
Date Acceptance
2016-07-22
Citation
Breast Cancer Research and Treatment, 2016, 159 (1), pp.195-195
ISSN
0167-6806
Publisher
Springer Verlag
Start Page
195
End Page
195
Journal / Book Title
Breast Cancer Research and Treatment
Volume
159
Issue
1
Copyright Statement
© The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Sponsor
Cancer Research UK
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000382847800075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
C37/A9335
Source
UK Breast Cancer Research Symposium
Subjects
Science & Technology
Life Sciences & Biomedicine
Oncology
Publication Status
Published
Start Date
2016-07-22
Finish Date
2016-07-23
Coverage Spatial
London, ENGLAND